Duff & Phelps Investment Management Co. Cuts Holdings in Sabra Healthcare REIT, Inc. $SBRA

Duff & Phelps Investment Management Co. reduced its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,472,988 shares of the real estate investment trust’s stock after selling 76,450 shares during the period. Duff & Phelps Investment Management Co. owned 0.99% of Sabra Healthcare REIT worth $46,096,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SBRA. Oppenheimer & Co. Inc. grew its holdings in Sabra Healthcare REIT by 1.7% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock valued at $633,000 after buying an additional 581 shares in the last quarter. Journey Strategic Wealth LLC grew its holdings in shares of Sabra Healthcare REIT by 3.3% in the third quarter. Journey Strategic Wealth LLC now owns 18,479 shares of the real estate investment trust’s stock valued at $344,000 after purchasing an additional 595 shares in the last quarter. Natixis Advisors LLC grew its holdings in shares of Sabra Healthcare REIT by 2.2% in the third quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock valued at $516,000 after purchasing an additional 598 shares in the last quarter. Amalgamated Bank increased its position in Sabra Healthcare REIT by 0.6% in the third quarter. Amalgamated Bank now owns 105,159 shares of the real estate investment trust’s stock worth $1,960,000 after purchasing an additional 612 shares during the last quarter. Finally, Private Advisor Group LLC increased its position in Sabra Healthcare REIT by 2.1% in the third quarter. Private Advisor Group LLC now owns 37,193 shares of the real estate investment trust’s stock worth $693,000 after purchasing an additional 750 shares during the last quarter. 99.40% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on SBRA shares. Citizens Jmp increased their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Cantor Fitzgerald boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Tuesday, February 17th. Wells Fargo & Company upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Thursday, January 22nd. Finally, Wall Street Zen lowered Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $21.80.

Sabra Healthcare REIT Stock Down 0.8%

Shares of SBRA opened at $20.65 on Thursday. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. The business has a fifty day moving average of $19.58 and a 200 day moving average of $18.99. The company has a market cap of $5.21 billion, a PE ratio of 32.27, a P/E/G ratio of 1.67 and a beta of 0.64. Sabra Healthcare REIT, Inc. has a 52-week low of $15.75 and a 52-week high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. During the same quarter last year, the firm earned $0.36 EPS. The company’s revenue was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Friday, February 13th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 5.8%. The ex-dividend date was Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is presently 187.50%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.